Definitive Contract HHSN268200900048C

This is a Definitive Contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Case Western Reserve University in Cleveland, Ohio. The contract is for a Biomedical Clinical Trial to Study Systolic Blood Pressure, under the Systolic Blood Pressure Intervention Trial (SPRINT) program. The contract has a Firm Fixed Price of $19,535,881.06 and runs from September 15, 2009 through March 20, 2020. There was no set-aside...

This federal contract award is for a biomedical clinical trial to study systolic blood pressure, awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency under the Department of Health and Human Services, to the University of Utah's Office of Sponsored Projects Division. The contract has a ceiling value of $24,519,297.30 and is a definitive contract with cost-no-fee pricing. The award is not set aside for any specific type of business. The University of Utah, a major...

This contract, awarded by the National Institute of Child Health and Human Development, provides Biopac Systems, Inc. with $24,035.00 to deliver blood pressure monitors. The contract is a firm fixed-price purchase order with a completion date of June 26, 2020. Biopac Systems, Inc. is a manufacturer of specialized biomedical research equipment and this award is not associated with a set-aside program. The company has a history of providing physiological monitoring devices, data acquisition...

This federal contract award is for the acquisition of a SphygmoCor System from Atcor Medical Inc. USA, doing business as Atcor Medical Holdings LTD in Sidney Australia. The National Institutes of Health National Institute of Child Health and Human Development is funding this $25,200 purchase order on behalf of the National Institute of Digestive and Diabetes and Kidney Diseases. The SphygmoCor System is a non-invasive device used to measure central blood pressure and pulse wave velocity. This...

This is a $666,052.25 Time and Materials contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH), to PPD Development LP, a global contract research organization. The contract is for clinical site and study monitoring support services for the NHLBI's Hypertension Outcomes for T4 Research within Lower Middle-Income Countries (HY-TREC) program. The contract was awarded on April 25, 2019 with a completion date of July 25, 2024. The...

The National Institutes of Health's National Heart, Lung and Blood Institute (NHLBI) awarded a $3.1 million firm fixed price contract to Siemens Medical Solutions USA, Inc. for a bi-plane X-ray cardiovascular intervention imaging system. The contract is being carried out from June 2021 through June 2023. Per the solicitation, NHLBI required the system to support pre-clinical and clinical research in structural heart interventions. Siemens will deliver and install the bi-plane X-ray system at...

The University of Alabama at Birmingham (UAB) was awarded a federal contract by the National Heart, Lung, and Blood Institute (NHLBI) for $7,967,653.41 to support the Coronary Artery Risk Development in Young Adults (CARDIA) study. The contract, which runs from July 2018 to June 2023, does not have a set-aside designation. As the prime contractor, UAB is responsible for various tasks including blood sample tracking and inventory, DNA extraction and distribution, data security, and freezer...

This $1,429,138.43 firm fixed price delivery order was awarded to Spaulding Clinical Research, LLC by the Food and Drug Administration (FDA), a civilian agency of the U.S. government. The delivery order was issued under Spaulding's $30 million Indefinite Delivery Indefinite Quantity (IDIQ) contract with the FDA for clinical and laboratory applied regulatory science services. The delivery order is for clinical electrocardiogram (ECG) studies to evaluate the electrophysiological effects of...

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $13,176.00 firm fixed price purchase order to Biopac Systems, Inc., a for-profit manufacturer and supplier of biomedical research equipment and software, to provide a cardiac bioimpedance system. The contract is set aside for small businesses and will be used to conduct experiments measuring bioimpedance to study blood flow in the Imaging Physics Laboratory. Biopac Systems,...

This is a federal contract award from the National Heart, Lung and Blood Institute (NHLBI) to the University of Alabama at Birmingham (UAB) for the Coronary Artery Risk Development in Young Adults (CARDIA) Study Coordinating Center. The $21,508,390.00 contract has an ultimate completion date of June 30, 2033 and is not set aside. The CARDIA study aims to assess the evolution of coronary artery disease risk factors in healthy young adults. UAB is the prime contractor, and key subcontractors...